Position in MRK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$226,288
+$18,067 QoQ
Shares Held
1,761
+1.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#3,425
of 3,769 holders
Holding Since
Jun 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Slagle Financial, LLC holds $9,819,740 across 7 Drug Manufacturers - General names. MRK ranks #5 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,066 | $4,080,282 | |
| 2 | AMGN |
Amgen Inc
|
9,098 | $3,294,567 | |
| 3 | ABBV |
AbbVie Inc.
|
5,092 | $1,281,350 | |
| 4 | LLY |
ELI LILLY & Co
|
413 | $495,364 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
1,761 | $226,288 | |
| 6 | PFE |
Pfizer Inc
|
9,185 | $221,174 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,747 | $220,715 |
All Filings in MRK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,288 | 1,761 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $208,221 | 1,731 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $209,677 | 1,992 | Shares | Sole | 2026-01-26 | |
| 2024-12-31 | $232,683 | 2,339 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $289,010 | 2,545 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $349,487 | 2,823 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,652,063 | 20,099 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $3,527,015 | 32,352 | Shares | Sole | 2024-03-05 | |
| 2023-09-30 | $1,650,082 | 16,028 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,714,003 | 14,854 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||